Results 81 to 90 of about 16,187 (190)

Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model.

open access: yesPLoS ONE, 2015
IntroductionNeuroblastoma is a malignant pediatric cancer derived from neural crest cells. It is characterized by a generalized reduction of mitochondrial oxidative phosphorylation.
Raphael Johannes Morscher   +7 more
doaj   +1 more source

Managing Metastatic Thymoma With Metabolic and Medical Therapy: A Case Report

open access: yesFrontiers in Oncology, 2020
Thymomas consist of neoplastic thymic cells intermixed with variable numbers of non-neoplastic lymphocytes. Metastatic thymomas are typically managed with non-curative chemotherapy to control tumor-related symptoms; no prolonged survival is expected ...
Matthew C. L. Phillips   +3 more
doaj   +1 more source

The Hypometabolic State of the Migraine Brain: Is a Ketogenic Diet the Answer?

open access: yesBrain and Behavior
Background Migraine pathophysiology involves a constellation of metabolic abnormalities. These interlinked contributory factors include mitochondrial dysfunction, an altered gut microbiome, neuroinflammation, oxidative stress, weight imbalance, and ...
Lakshini Gunasekera   +5 more
doaj   +1 more source

Long-Term Ketogenic Diet Induces Metabolic Acidosis, Anemia, and Oxidative Stress in Healthy Wistar Rats

open access: yesJournal of Nutrition and Metabolism, 2020
Background. Ketogenic diet has been used as supportive therapy in a range of conditions including epilepsy, diabetes mellitus, and cancer. Objective.
Aryadi Arsyad   +9 more
doaj   +1 more source

Spanish Ketogenic Mediterranean diet: a healthy cardiovascular diet for weight loss [PDF]

open access: yes, 2008
Background Ketogenic diets are an effective healthy way of losing weight since they promote a non-atherogenic lipid profile, lower blood pressure and decrease resistance to insulin with an improvement in blood levels of glucose and insulin.
Joaquín Pérez-Guisado   +45 more
core   +2 more sources

Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders [PDF]

open access: yes, 2018
High-fat, low-carbohydrate diets, known as ketogenic diets, have been used as a non-pharmacological treatment for refractory epilepsy. A key mechanism of this treatment is thought to be the generation of ketones, which provide brain cells (neurons and ...
Augustin, Katrin   +8 more
core   +2 more sources

Ketogenic diet treatment in adults with glycogenosis type IIIa (Morbus Cori)

open access: yesClinical Nutrition Experimental, 2019
Summary: Background: Glycogen storage disease type IIIa (GSDIIIa) is a defect of the debranching enzyme (amylo-1,6-glucosidase) in glycogenolysis and has an effect on the muscles and the liver.
Tobias Fischer   +4 more
doaj   +1 more source

"Electro-clinical Syndromes" with onset in Paediatric Age. the highlights of the clinical-EEG, genetic and therapeutic advances [PDF]

open access: yes, 2011
The genetic causes underlying epilepsy remain largely unknown, and the impact of available genetic data on the nosology of epilepsy is still limited.
PARISI, Pasquale   +7 more
core   +1 more source

Incidence and phenotypes of childhood-onset genetic epilepsies:a prospective population-based national cohort [PDF]

open access: yes, 2019
Epilepsy is common in early childhood. In this age group it is associated with high rates of therapy-resistance, and with cognitive, motor, and behavioural comorbidity. A large number of genes, with wide ranging functions, are implicated in its aetiology,
Abdelnour   +112 more
core   +4 more sources

From glucose to histone modification: sex-specific metabolic responses to ketogenic therapy in VM/Dk mice

open access: yesFrontiers in Nutrition
IntroductionThe assessment of sex-specific effects in pre-clinical models is critical for improving the translatability of findings to clinical applications.
Sara E. Moss   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy